Prosecution Insights
Last updated: April 19, 2026

Marengo Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18172928 ANTIBODY MOLECULES THAT BIND TO NKP30 AND USES THEREOF SUNSHINE, HANNAH LOUISE 1647 Non-Final OA Feb 22, 2023
17584892 MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF CANELLA, KAREN A 1643 Final Rejection Jan 26, 2022

Managing Marengo Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month